Clinical Trials Logo

Clinical Trial Summary

The objective of the study is to investigate whether blood markers can be used to predict the development of bone metastases and to assess the efficacy and safety of zoledronic acid in cancer treatment induced bone loss.


Clinical Trial Description

n/a


Study Design


Related Conditions & MeSH terms


NCT number NCT00172055
Study type Interventional
Source Novartis
Contact
Status Completed
Phase Phase 3
Start date December 2004
Completion date July 2009

See also
  Status Clinical Trial Phase
Recruiting NCT06152419 - Patient Education Videos to Improve Patients' Experience During Radiotherapy Treatment: a National Project N/A
Active, not recruiting NCT05410002 - Diet Effect on Cancer Treatment Outcome Phase 1
Completed NCT04836221 - Comorbidities And Reducing inEquitieS N/A
Terminated NCT03157856 - Assessment of a New Fluorescence Imaging Technique Using Biopsies From Prostate Resection
Not yet recruiting NCT06035731 - Evaluation of the Medical Service by Socio-aesthetics in Oncology N/A
Not yet recruiting NCT05154474 - Assessment of Sarcopenia at Diagnosis for Patients With Previously Untreated Metastatic Cancer or Hematologic Malignancy
Active, not recruiting NCT06359717 - Prospective Validation of PSMA-RADS
Recruiting NCT03452774 - SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
Completed NCT04074460 - Volatile Anaesthesia and Perioperative Outcomes Related to Cancer Feasibility Study Phase 4
Completed NCT03866785 - Physical Activity Experiment on Male Prostate Cancer Patients N/A